Clinical Trial Update: Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 [Phase 1]

View source ↗

Summary

Phase 1 study update reporting completion of single- and multiple-ascending-dose pharmacology evaluation of KAR5585 in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• KAR5585

Snippet

Sponsor: Karos Pharmaceuticals | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED